Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ador Multiproducts Limited (BSE scrip code 523120) submitted the newspaper publication of its audited standalone and consolidated financial results for the financial year ended 31 March 2025. On a standalone basis, total income from operations rose sharply to Rs 217.97 lakh from Rs 65.17 lakh in FY24, but the company slipped deeper into loss with a net loss after tax of Rs 63.55 lakh versus Rs 33.02 lakh the previous year. On a consolidated basis, revenue climbed to Rs 515.14 lakh from Rs 65.62 lakh, while the loss after tax widened significantly, dragged down by the company's two subsidiaries — 58% in Anamoticals Ador India Pvt Ltd and 52.75% in 1908 E-Ventures Pvt Ltd. Equity share capital stayed at Rs 467.36 lakh and EPS remained negative. The results were reviewed by the Audit Committee and approved by the Board on 16 May 2025.
Despite strong revenue growth, widening losses at both standalone and consolidated levels signal cost or margin pressure, with subsidiaries amplifying the consolidated loss — a negative signal for near-term shareholder value, though revenue momentum is a modest positive.